Clinical Trials Logo
  1. Home
  2. Healthy Volunteers
  3. NCT00333606
  4. Details
NCT00333606 Clinical Trial

Acupuncture and Auditory Evoked Potentials

Healthy Volunteers Clinical Trial

Official title:
Effects of Acupuncture on the Auditory Evoked Potentials: a Randomized Volunteer Crossover Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00333606
Other study ID # III UV 12/06
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2005
Est. completion date March 2009

Study information
Verified date April 2017
Source University Medicine Greifswald
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To investigate whether body acupuncture of acupuncture points specific for hearing influences the auditory avoked potentials in comparison to puncture of non-specific acupuncture points

Recruitment information / eligibility
Status Completed
Enrollment 60
Est. completion date March 2009
Est. primary completion date February 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

1. Healthy volunteers aged 20-40 years

2. Physical status I according to American Society of Anesthesiologists (ASA) classification

3. No history of nervous or psychiatric disease

4. Normal audiogram before the study

5. No chronic consume of analgesics, anticoagulants and/or antiplatelet agents, sedatives or alcohol

6. No local infection at the site of acupuncture

7. Volunteers who have given informed consent

Exclusion Criteria:

1. Pregnant or nursing females.

2. History of peripheral neuropathy

3. Abnormal skin conditions (infection, scars, psoriasis, eczema)

4. Inflamed site of acupuncture within 1 week

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Acupuncture
Body acupuncture of 1 specific point per trial session

Locations
Country Name City State
Germany Ernst Moritz Arndt University Greifswald

Sponsors (1)
Lead Sponsor Collaborator
Taras Usichenko

Country where clinical trial is conducted

Germany, 

Outcome
Type Measure Description Time frame Safety issue
Primary Latencies of Auditory Evoked Potentials before acupuncture stimulation
Secondary Pain Intensity Visual Analogue Scale 0-100 mm, where 0=no pain, and 100=maximal pain 30 min
See also
  Status Clinical Trial Phase
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1